Wavemaker Three-Sixty Health
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Wavemaker Three-Sixty Health.
Key people at Wavemaker Three-Sixty Health.
Key people at Wavemaker Three-Sixty Health.
Wavemaker Three-Sixty Health (Wavemaker 360) is a leading U.S.-based early-stage venture capital fund exclusively focused on healthcare technology startups, primarily at the seed stage. Its mission is to invest in and support innovative health-tech companies that are transforming healthcare delivery by improving patient outcomes, lowering costs, and enhancing the experience for clinicians and patients alike. The firm targets sectors including software, AI, tech-enabled services, and medical devices, backing startups that address critical challenges across the healthcare continuum. Wavemaker 360 leverages a unique network of over 400 Limited Partners who are healthcare industry insiders, providing deep domain expertise and commercial support to portfolio companies, which significantly strengthens their growth momentum and market impact[1][2][3].
Founded in 2017 and headquartered in Pasadena, California, Wavemaker 360 started with a small team and has grown to over 15 professionals with offices in Los Angeles and New York. The founding partners include healthcare executives, clinicians, FDA experts, technologists, and experienced entrepreneurs, reflecting a cross-functional team that blends investment acumen with healthcare operational knowledge. The firm’s origin stems from recognizing the need for specialized venture capital that understands healthcare’s complexities and can provide more than just capital—offering strategic guidance and industry connections. Early traction was marked by rapid growth in investments, reaching over 60 startups globally, including companies in the U.S., Singapore, Canada, and Europe[1][2][6].
Wavemaker 360 rides the wave of digital transformation in healthcare, capitalizing on trends such as AI integration, telehealth expansion, value-based care, and patient-centric solutions. The timing is critical as healthcare costs approach 20% of GDP, creating urgency for innovations that improve outcomes while reducing expenses. The firm’s focus on software and tech-enabled services aligns with the shift toward data-driven, scalable healthcare solutions. By backing startups that serve clinicians, patients, and payers, Wavemaker 360 influences the broader ecosystem by accelerating adoption of disruptive technologies and fostering a more efficient, patient-friendly healthcare system[1][3].
Wavemaker Three-Sixty Health is poised to continue its leadership in early-stage healthcare investing by expanding its portfolio and deepening its strategic support capabilities. Future trends likely to shape its journey include increased AI adoption in diagnostics and care management, growth in telehealth and remote monitoring, and innovations addressing healthcare affordability and access. As healthcare continues to evolve rapidly, Wavemaker 360’s unique model of leveraging industry insider expertise positions it to remain a key catalyst in transforming healthcare delivery and outcomes globally[1][2][3].
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | AiDASH | $59.0M Series C | — | Benhamou Global Ventures, Blockchange Ventures, First Rays Venture Partners, G2VP, National Grid Partners, Mike Abbott |
| May 1, 2023 | Essenvia | $4.0M Seed | — | Benhamou Global Ventures, Cyberstarts VC, First Rays Venture Partners, Plug & Play Ventures, StageOne Ventures, WestWave Capital, Amir Jerbi, Shlomo Kramer, Yevgeny Dibrov |
| Oct 1, 2021 | AiDASH | $27.0M Series B | — | Benhamou Global Ventures, Blockchange Ventures, First Rays Venture Partners, G2VP, Momenta Ventures, National Grid Partners, NextGen Venture Partners, Mike Abbott |
| Oct 1, 2020 | AiDASH | $6.0M Series A | — | Benhamou Global Ventures, First Rays Venture Partners, G2VP, Momenta Ventures, National Grid Partners, NextGen Venture Partners |
